Intermediate-dose intramuscular methylprednisolone acetate in the treatment of rheumatic disease.
Treatment with a high-dose, intravenous bolus of methylprednisolone has been reported in numerous cases of rheumatic diseases. The optimal routes of administration, dosage, dosage interval, and other factors are unknown. This report describes uncontrolled clinical observations with a single dose of...
Spremljeno u:
| Izdano u: | Ann Rheum Dis |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMJ Publishing Group
1983
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1001138/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6602594/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.42.3.308 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|